» Articles » PMID: 23393670

Type 2 Diabetes Mellitus, Pandemic in 21st Century

Overview
Date 2013 Feb 9
PMID 23393670
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

In the second half of the 20th century it became obvious that a relentless increase in Type 2 diabetes mellitus (T2DM), affecting the economically affluent countries, is gradually afflicting also the developing world. This chapter shows the threat that the T2DM epidemic represents to mankind, with the astonishing recent discoveries on the role of obesity and of body fat in this metabolic disorder. Presently, the highest prevalence of T2DM is in Saudi Arabia. T2DM is very high in over 10% of adults in the USA, Switzerland and Austria. Prevalence is low in Norway, China and in Iceland. Predictions of epidemiologists for the first third of the 21st century claim up to 2.5 times increase in the prevalence of T2DM in the Middle East, Sub-Saharan Africa, India, rest of Asia and in the Latin America. In China the number of patients with T2DM will double in 2030. In the economically advanced countries the increase will be about 50% in 2030. Increasing urbanization, aging populations, obesity and falling levels of physical activity are all contributing to the rise of T2DM worldwide. The main cause of T2DM pandemic is growing prevalence of obesity in Europe and USA. In the North America and European Union countries obesity is considered to be responsible for up to 70-90% of T2DM in adult population. The precise mechanism by which obesity leads to insulin resistance and to T2DM is not completely known but it may be related to several biochemical factors such as abnormalities in free fatty acids, adipokines, leptin and other substances.

Citing Articles

MiRNAs as biomarkers of nutritional therapy to achieve T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.

Alcala-Diaz J, Camargo A, Vals-Delgado C, Leon-Acuna A, Garcia-Fernandez H, Arenas-de Larriva A Nutr Diabetes. 2025; 15(1):7.

PMID: 39987252 PMC: 11846967. DOI: 10.1038/s41387-025-00362-1.


Cross-sectional study on prevalence and risk factors of undiagnosed type 2 diabetes among patients with hypertension attending St. Orsola Catholic Mission Hospital, Tharaka Nithi County, Kenya.

Emilioh G, Nyagero J, Shoo R Pan Afr Med J. 2025; 49():41.

PMID: 39867544 PMC: 11760203. DOI: 10.11604/pamj.2024.49.41.44119.


Effects of combined aerobic exercise and diet on cardiometabolic health in patients with obesity and type 2 diabetes: a systematic review and meta-analysis.

Al-Mhanna S, Rocha-Rodriguesc S, Mohamed M, Batrakoulis A, Aldhahi M, Afolabi H BMC Sports Sci Med Rehabil. 2023; 15(1):165.

PMID: 38049873 PMC: 10696788. DOI: 10.1186/s13102-023-00766-5.


Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis.

Fenta E, Eshetu H, Kebede N, Bogale E, Zewdie A, Kassie T Diabetol Metab Syndr. 2023; 15(1):245.

PMID: 38012781 PMC: 10683270. DOI: 10.1186/s13098-023-01202-x.


In vivo antioxidant and hypoglycaemic potentials of extract against streptozotocin induced diabetes and its complications in wistar rats.

C R, Ghosh K, A S, Rawal P, Pramanik S J Diabetes Metab Disord. 2023; 22(2):1373-1383.

PMID: 37975104 PMC: 10638325. DOI: 10.1007/s40200-023-01258-6.